Low levels of amniotic fluid placental alkaline phosphatase in Down's syndrome. 1993

T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
Department of Obstetrics, Gynaecology, St. Bartholomew's Hospital, London, UK.

OBJECTIVE To investigate amniotic fluid placental alkaline phosphatase (PLAP) levels in normal and trisomy 21 pregnancies. METHODS Cross sectional study. METHODS A tertiary referral prenatal diagnostic service. METHODS Three hundred and eleven women with singleton pregnancies of normal karyotype between 10 and 23 weeks gestation and 31 women with pregnancies associated with trisomy 21 Down's syndrome. METHODS PLAP levels were measured by immunoradiometric assay in amniotic fluid obtained by amniocentesis. RESULTS Amniotic fluid PLAP was detectable from 12 weeks gestation and the median value rose to a peak of 4.57 iu/l at 18 weeks. Pregnancies associated with Down's syndrome had significantly lower levels with a median multiple of median (MoM) of 0.638, (U = 3374, P = 0.0016, 95% CI = 0.50, 0.89). For the 20 women with trisomy 21 pregnancies detected at 16 to 18 weeks, the median MoM was 0.482, (U = 3694, P = 0.0011, 95% CI = 0.37, 0.85). CONCLUSIONS These data demonstrates that PLAP levels are reduced in the amniotic fluid of women carrying a fetus with trisomy 21.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011295 Prenatal Care Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. Antenatal Care,Care, Antenatal,Care, Prenatal
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid

Related Publications

T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
August 1981, Ceskoslovenska patologie,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
September 1994, European journal of obstetrics, gynecology, and reproductive biology,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
January 1974, Acta obstetricia et gynecologica Scandinavica. Supplement,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
March 1971, American journal of mental deficiency,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
May 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
September 1960, Zentralblatt fur Gynakologie,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
January 2009, Fetal diagnosis and therapy,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
December 1987, Clinical biochemistry,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
January 1982, Soudni lekarstvi,
T E Ind, and R K Iles, and N C Wathen, and P Murugan, and J Campbell, and M Macintosh, and T Chard
January 1966, Acta genetica et statistica medica,
Copied contents to your clipboard!